CompletedNCT00856973
What is this study about?Researchers compared eszopiclone and placebo, tracking side effects to assess safety in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamADHDMedication studyAges 6–17
- Countries
- United States
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT00419445
Official study titleA Double-Blind, Randomized, Proof-of-Concept Crossover Trial to Assess the Effects of GTS21 on Cognitive Function, Clinical Symptoms, and Adverse Events in Adults Diagnosed With Attention-Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Washington D.C.ADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- CoMentis
CompletedNCT02466386
What is this study about?Researchers studied SPD489, tracking side effects to assess safety and tolerability in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanADHDMedication studyAges 4–5
- Countries
- United States
- Sponsor
- Shire
CompletedNCT02402166
What is this study about?This study evaluated the safety and effectiveness of SPD489 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachADHDMedication studyAges 4–5
- Countries
- United States
- Sponsor
- Shire
CompletedNCT04104841
This study has finished and is no longer accepting participants.
In College ParkADHD, DepressionBehavioural studyAges 14–18
- Countries
- United States
- Sponsor
- University of Maryland, College Park
TerminatedNCT05222321
Official study titleSensory-Play Based (SenPlay) Intervention for Young Children With or At Risk for Attention Deficit Hyper Activity Disorder (ADHD)
This study ended early.
In YukonADHDPlacebo comparisonAges 36–71 months
- Countries
- United States
- Sponsor
- University of Oklahoma
CompletedNCT01816074
This study has finished and is no longer accepting participants.
In SeattleADHDMedication studyAges 21–50
- Countries
- United States
- Sponsor
- Seattle Children's Hospital
CompletedNCT06406309
Official study titleSettling Down for Sleep: The Impact of Sensory and Arousal Systems on Sleep in ADHD
This study has finished and is no longer accepting participants.
In PittsburghADHDBehavioural studyAges 6–13
- Countries
- United States
- Sponsor
- University of Pittsburgh
CompletedNCT01019252
Official study titleCompensatory Executive Functioning Skills Training in Adolescents With ADHD
This study has finished and is no longer accepting participants.
In BostonADHDBehavioural studyAges 14–18
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT02897362
This study has finished and is no longer accepting participants.
In DurhamADHDObservational studyAges 13–17
- Countries
- United States
- Sponsor
- Duke University
CompletedNCT05778526
Official study titleEffectiveness of Social Virtual-reality on Enhancing Social Interaction Skills in Children With Attention-deficit/Hyperactivity Disorder: a Three-arm Pilot Randomised Controlled Trial
This study has finished and is no longer accepting participants.
In Hong KongADHDBehavioural studyAges 6–12
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University
CompletedNCT03649074
Official study titleSoftware Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant (STARS-ADHD Adjunctive)
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleADHDDevice studyAges 8–14
- Countries
- United States
- Sponsor
- Akili Interactive Labs, Inc.